Arkolith/Insider Trading/LYEL/Form 4

Innovative Cellular Therapeutics Holdings Ltd

10% OwnerLyell Immunopharma, Inc. (LYEL) · full profile →Form 4 · filed Jun 19, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 15, 2026Other(J)67K—$02.9M

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-26-025796) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML